Consolidated revenue grew 15% to ₹14,997.87 million, with EBITDA and PAT margins at 22.89% and 12.95%, respectively. Expansion continued with the Dombivli hospital opening and new projects underway, while disciplined capital allocation and a patient-first approach supported operational and financial resilience.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.